2259 related articles for article (PubMed ID: 19682910)
1. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA
Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910
[TBL] [Abstract][Full Text] [Related]
2. New pyrazoline bearing 4(3H)-quinazolinone inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity.
Gökhan-Kelekçi N; Koyunoğlu S; Yabanoğlu S; Yelekçi K; Ozgen O; Uçar G; Erol K; Kendi E; Yeşilada A
Bioorg Med Chem; 2009 Jan; 17(2):675-89. PubMed ID: 19091581
[TBL] [Abstract][Full Text] [Related]
3. Sulfur-substituted alpha-alkyl phenethylamines as selective and reversible MAO-A inhibitors: biological activities, CoMFA analysis, and active site modeling.
Gallardo-Godoy A; Fierro A; McLean TH; Castillo M; Cassels BK; Reyes-Parada M; Nichols DE
J Med Chem; 2005 Apr; 48(7):2407-19. PubMed ID: 15801832
[TBL] [Abstract][Full Text] [Related]
4. Docking studies on monoamine oxidase-B inhibitors: estimation of inhibition constants (K(i)) of a series of experimentally tested compounds.
Toprakçí M; Yelekçi K
Bioorg Med Chem Lett; 2005 Oct; 15(20):4438-46. PubMed ID: 16137882
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, molecular modeling studies, and selective inhibitory activity against monoamine oxidase of 1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-(1H)- pyrazole derivatives.
Chimenti F; Maccioni E; Secci D; Bolasco A; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F; Cirilli R; La Torre F; Cardia MC; Distinto S
J Med Chem; 2005 Nov; 48(23):7113-22. PubMed ID: 16279769
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of new series of quinoxaline based MAO-inhibitors and docking studies.
Khattab SN; Hassan SY; Bekhit AA; El Massry AM; Langer V; Amer A
Eur J Med Chem; 2010 Oct; 45(10):4479-89. PubMed ID: 20708306
[TBL] [Abstract][Full Text] [Related]
7. Monoamine oxidase inhibition by selected anilide derivatives.
Legoabe L; Kruger J; Petzer A; Bergh JJ; Petzer JP
Eur J Med Chem; 2011 Oct; 46(10):5162-74. PubMed ID: 21899930
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, in vitro MAO-B inhibitory evaluation, and computational studies of some 6-nitrobenzothiazole-derived semicarbazones.
Tripathi RK; Goshain O; Ayyannan SR
ChemMedChem; 2013 Mar; 8(3):462-74. PubMed ID: 23325700
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor.
Pisani L; Muncipinto G; Miscioscia TF; Nicolotti O; Leonetti F; Catto M; Caccia C; Salvati P; Soto-Otero R; Mendez-Alvarez E; Passeleu C; Carotti A
J Med Chem; 2009 Nov; 52(21):6685-706. PubMed ID: 19810674
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and selective inhibitory activity of 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives against monoamine oxidase.
Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Befani O; Turini P; Giovannini V; Mondovì B; Cirilli R; La Torre F
J Med Chem; 2004 Apr; 47(8):2071-4. PubMed ID: 15056004
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, structure-activity relationships and molecular modeling studies of new indole inhibitors of monoamine oxidases A and B.
La Regina G; Silvestri R; Gatti V; Lavecchia A; Novellino E; Befani O; Turini P; Agostinelli E
Bioorg Med Chem; 2008 Nov; 16(22):9729-40. PubMed ID: 18951803
[TBL] [Abstract][Full Text] [Related]
13. New pyrrole inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity.
La Regina G; Silvestri R; Artico M; Lavecchia A; Novellino E; Befani O; Turini P; Agostinelli E
J Med Chem; 2007 Mar; 50(5):922-31. PubMed ID: 17256833
[TBL] [Abstract][Full Text] [Related]
14. 1,3,4-Oxadiazole-3(2H)-carboxamide derivatives as potential novel class of monoamine oxidase (MAO) inhibitors: synthesis, evaluation, and role of urea moiety.
Ke S; Li Z; Qian X
Bioorg Med Chem; 2008 Aug; 16(16):7565-72. PubMed ID: 18678501
[TBL] [Abstract][Full Text] [Related]
15. Selective inhibitory activity against MAO and molecular modeling studies of 2-thiazolylhydrazone derivatives.
Chimenti F; Maccioni E; Secci D; Bolasco A; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F; Cardia MC; Distinto S
J Med Chem; 2007 Feb; 50(4):707-12. PubMed ID: 17253676
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and inhibition study of monoamine oxidase, indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase by 3,8-substituted 5H-indeno[1,2-c]pyridazin-5-one derivatives.
Reniers J; Meinguet C; Moineaux L; Masereel B; Vincent SP; Frederick R; Wouters J
Eur J Med Chem; 2011 Dec; 46(12):6104-11. PubMed ID: 22018876
[TBL] [Abstract][Full Text] [Related]
17. Towards development of selective and reversible pyrazoline based MAO-inhibitors: Synthesis, biological evaluation and docking studies.
Sahoo A; Yabanoglu S; Sinha BN; Ucar G; Basu A; Jayaprakash V
Bioorg Med Chem Lett; 2010 Jan; 20(1):132-6. PubMed ID: 19945874
[TBL] [Abstract][Full Text] [Related]
18. Development of selective and reversible pyrazoline based MAO-A inhibitors: Synthesis, biological evaluation and docking studies.
Karuppasamy M; Mahapatra M; Yabanoglu S; Ucar G; Sinha BN; Basu A; Mishra N; Sharon A; Kulandaivelu U; Jayaprakash V
Bioorg Med Chem; 2010 Mar; 18(5):1875-81. PubMed ID: 20149663
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors.
Matos MJ; Viña D; Picciau C; Orallo F; Santana L; Uriarte E
Bioorg Med Chem Lett; 2009 Sep; 19(17):5053-5. PubMed ID: 19628387
[TBL] [Abstract][Full Text] [Related]
20. Molecular docking of inhibitors into monoamine oxidase B.
Harkcom WT; Bevan DR
Biochem Biophys Res Commun; 2007 Aug; 360(2):401-6. PubMed ID: 17597580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
